Tonix Pharmaceuticals Holding (TNXP) Exchange Rate Effect (2013 - 2026)
Tonix Pharmaceuticals Holding's (TNXP) quarterly Exchange Rate Effect came in at $6000.0 in Q1 2026, up 166.67% year-on-year from $2250.0 in Q1 2025, and up 142.86% quarter-over-quarter from -$14000.0 in Q4 2025.
Tonix Pharmaceuticals Holding (TNXP) Exchange Rate Effect (2013 - 2026) Analysis & Trends
Tonix Pharmaceuticals Holding's Exchange Rate Effect history runs 14 years deep, the most recent figure standing at $6000.0 for Q1 2026.
- On a quarterly basis, Exchange Rate Effect rose 166.67% year-over-year to $6000.0 in Q1 2026; TTM through Mar 2026 was -$16000.0, a 1500.0% decrease from a year earlier, with the FY2025 full-year figure at -$31000.0, down 875.0% from the prior year.
- Exchange Rate Effect improved to $6000.0 in Q1 2026 per TNXP's latest filing, from -$14000.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $24000.0 in Q4 2024 and bottomed at -$43000.0 in Q1 2023.
- The 5-year median for Exchange Rate Effect is -$9500.0 (2023), against an average of -$10000.0.
- Across the five-year window, Exchange Rate Effect tumbled 2400.0% in 2022 and jumped 340.0% in 2024, its largest moves.
- Year by year, Exchange Rate Effect stood at -$5000.0 in 2022, then plunged by 100.0% to -$10000.0 in 2023, then jumped by 340.0% to $24000.0 in 2024, then plunged by 158.33% to -$14000.0 in 2025, then soared by 142.86% to $6000.0 in 2026.
- Per Business Quant, the three latest TNXP Exchange Rate Effect figures stand at $6000.0 (Q1 2026), -$14000.0 (Q4 2025), and -$4000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 619,347.27 |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 19.32 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | -40.30 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -900,000.00 |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Tonix Pharmaceuticals Holding | 142.07 Mn | 142.07 Mn | 5.30 Mn | 6,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6,000.00 |
| Mar 31, 2026 | 6,000.00 |
| Dec 31, 2025 | -14,000.00 |
| Dec 31, 2025 | -14,000.00 |
| Sep 30, 2025 | -4,000.00 |
| Sep 30, 2025 | -4,000.00 |
| Jun 30, 2025 | -4,000.00 |
| Jun 30, 2025 | -4,000.00 |
| Mar 31, 2025 | -9,000.00 |
| Mar 31, 2025 | -9,000.00 |
| Dec 31, 2024 | 24,000.00 |
| Dec 31, 2024 | 24,000.00 |
| Sep 30, 2024 | -17,000.00 |
| Sep 30, 2024 | -17,000.00 |
| Jun 30, 2024 | 1,000.00 |
| Jun 30, 2024 | 1,000.00 |
| Mar 31, 2024 | -4,000.00 |
| Mar 31, 2024 | -4,000.00 |
| Dec 31, 2023 | -10,000.00 |
| Dec 31, 2023 | -10,000.00 |